BACKGROUND: Our purpose was to determine the prevalence of specific types of CHD among non-Hispanic (NH)-Black, NH-White, and Hispanic infants. METHODS: We conducted a retrospective cohort study with 9,352 singleton infants diagnosed with conotruncal, right or left obstructive or septal CHDs from the Florida Birth Defects Registry, born 1998-2003 to resident NH-White, NH-Black, and Hispanic women aged 15-49. Defect-specific prevalence rates, prevalence ratios and P-values were calculated for each type of CHD and by number of defects for each racial/ethnic group. RESULTS: Compared to NH-Whites, NH-Blacks had higher rates of pulmonary valve atresia/stenosis but lower frequency of aortic valve atresia/stenosis and ventricular septal defect. Hispanics had lower rates of aortic valve atresia/stenosis and atrioventricular septal defects than NH-Whites. CONCLUSIONS: Although few racial/ethnic differences in prevalence are present among infants with major CHD, observed differences are clinically meaningful. However, the underlying etiologies for the observed differences remain unknown.
BACKGROUND: Our purpose was to determine the prevalence of specific types of CHD among non-Hispanic (NH)-Black, NH-White, and Hispanic infants. METHODS: We conducted a retrospective cohort study with 9,352 singleton infants diagnosed with conotruncal, right or left obstructive or septal CHDs from the Florida Birth Defects Registry, born 1998-2003 to resident NH-White, NH-Black, and Hispanic women aged 15-49. Defect-specific prevalence rates, prevalence ratios and P-values were calculated for each type of CHD and by number of defects for each racial/ethnic group. RESULTS: Compared to NH-Whites, NH-Blacks had higher rates of pulmonary valve atresia/stenosis but lower frequency of aortic valve atresia/stenosis and ventricular septal defect. Hispanics had lower rates of aortic valve atresia/stenosis and atrioventricular septal defects than NH-Whites. CONCLUSIONS: Although few racial/ethnic differences in prevalence are present among infants with major CHD, observed differences are clinically meaningful. However, the underlying etiologies for the observed differences remain unknown.
Authors: Mark A Canfield; Cara T Mai; Ying Wang; Alissa O'Halloran; Lisa K Marengo; Richard S Olney; Christopher L Borger; Rachel Rutkowski; Jane Fornoff; Nila Irwin; Glenn Copeland; Timothy J Flood; Robert E Meyer; Russel Rickard; C J Alverson; Joseph Sweatlock; Russell S Kirby Journal: Am J Public Health Date: 2014-07-17 Impact factor: 9.308
Authors: Keila N Lopez; Carissa Baker-Smith; Glenn Flores; Michelle Gurvitz; Tara Karamlou; Flora Nunez Gallegos; Sara Pasquali; Angira Patel; Jennifer K Peterson; Jason L Salemi; Clyde Yancy; Shabnam Peyvandi Journal: J Am Heart Assoc Date: 2022-04-07 Impact factor: 6.106
Authors: Melissa A Richard; Jenil Patel; Renata H Benjamin; Emine Bircan; Stephen J Canon; Lisa K Marengo; Mark A Canfield; A J Agopian; Philip J Lupo; Wendy N Nembhard Journal: JAMA Netw Open Date: 2022-07-01